Diagnostics World | Researchers from Washington University School of Medicine, St. Louis have showed that elevated levels of a set of circular RNAs (circRNAs) in the blood nearly tripled patients’ risk of developing Alzheimer’s Disease (AD) symptoms, suggesting these molecules are more sensitive to symptom onset than traditional AD biomarkers.
